Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget's disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones. Loss on Drying: 5-7% Identification (IR): Conforms to structure Solubility: Water: 2mg/ml Storage and Stability: Lyophilized powder may be stored at 4C. Stable for 6 months after receipt.
Molecular Weight:
290.1
Purity:
98.5%
Form:
Supplied as a white to off-white crystalline powder
CAS Number:
[165800-06-6]
* VAT and and shipping costs not included. Errors and price changes excepted
